DK311580A - Fremgangsmaade til fremstilling af oxoalkylxanthiner - Google Patents
Fremgangsmaade til fremstilling af oxoalkylxanthinerInfo
- Publication number
- DK311580A DK311580A DK311580A DK311580A DK311580A DK 311580 A DK311580 A DK 311580A DK 311580 A DK311580 A DK 311580A DK 311580 A DK311580 A DK 311580A DK 311580 A DK311580 A DK 311580A
- Authority
- DK
- Denmark
- Prior art keywords
- oxoalkylxanthines
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792929596 DE2929596A1 (de) | 1979-07-21 | 1979-07-21 | Verfahren zur herstellung von oxoalkyl-xanthinen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK311580A true DK311580A (da) | 1981-01-22 |
Family
ID=6076378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK311580A DK311580A (da) | 1979-07-21 | 1980-07-18 | Fremgangsmaade til fremstilling af oxoalkylxanthiner |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0023032A1 (da) |
| JP (1) | JPS5616486A (da) |
| AR (1) | AR227645A1 (da) |
| DE (1) | DE2929596A1 (da) |
| DK (1) | DK311580A (da) |
| ES (1) | ES8105005A1 (da) |
| FI (1) | FI802267A7 (da) |
| GR (1) | GR69741B (da) |
| NO (1) | NO802173L (da) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0157098A1 (en) * | 1980-06-21 | 1985-10-09 | Beecham Wuelfing GmbH & Co KG | Xanthine derivatives, pharmaceuticals compositions containing them and a process for their preparation |
| GB8418430D0 (en) * | 1984-07-19 | 1984-08-22 | Beecham Wuelfing Gmbh & Co Kg | Treatment |
| GB8501488D0 (en) * | 1985-01-21 | 1985-02-20 | Beecham Group Plc | Treatment |
| US4851060A (en) * | 1987-08-12 | 1989-07-25 | Essex Group, Inc. | Multilayer wrapped insulated magnet wire |
| CA2030112A1 (en) * | 1989-11-24 | 1991-05-25 | Yasuo Ito | Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same |
| DE3942872A1 (de) * | 1989-12-23 | 1991-06-27 | Hoechst Ag | Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen |
| EP0570831A2 (de) * | 1992-05-20 | 1993-11-24 | Hoechst Aktiengesellschaft | Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| DE102005035891A1 (de) | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| CN102838599A (zh) | 2006-05-04 | 2012-12-26 | 贝林格尔.英格海姆国际有限公司 | 多晶型 |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| PE20091730A1 (es) | 2008-04-03 | 2009-12-10 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| KR20200118243A (ko) | 2008-08-06 | 2020-10-14 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
| BRPI0919288A2 (pt) | 2008-09-10 | 2015-12-15 | Boehring Ingelheim Internat Gmbh | teriapia de combinação para tratamento de diabetes e condições relacionadas. |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| EA022310B1 (ru) | 2008-12-23 | 2015-12-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Солевые формы органического соединения |
| AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
| NZ599298A (en) | 2009-11-27 | 2014-11-28 | Boehringer Ingelheim Int | Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin |
| WO2011138421A1 (en) | 2010-05-05 | 2011-11-10 | Boehringer Ingelheim International Gmbh | Combination therapy |
| NZ603319A (en) | 2010-06-24 | 2015-04-24 | Boehringer Ingelheim Int | Diabetes therapy |
| AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
| CA2841552C (en) | 2011-07-15 | 2020-06-23 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| US20130303554A1 (en) | 2012-05-14 | 2013-11-14 | Boehringer Ingelheim International Gmbh | Use of a dpp-4 inhibitor in sirs and/or sepsis |
| EP3685839A1 (en) | 2012-05-14 | 2020-07-29 | Boehringer Ingelheim International GmbH | Linagliptin for use in the treatment of albuminuria and kidney related diseases |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| WO2017211979A1 (en) | 2016-06-10 | 2017-12-14 | Boehringer Ingelheim International Gmbh | Combinations of linagliptin and metformin |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2336403A1 (fr) * | 1975-12-24 | 1977-07-22 | Bruneau & Cie Lab | Nouveau procede de preparation de l'acide (theophyllinyl-7)-3 propanesulfonique |
| GB1527543A (en) * | 1976-04-15 | 1978-10-04 | Degussa | Basically substituted xanthine derivatives |
| DE2714953C2 (de) * | 1977-04-02 | 1986-09-25 | Hoechst Ag, 6230 Frankfurt | Arzneimittel |
-
1979
- 1979-07-21 DE DE19792929596 patent/DE2929596A1/de not_active Withdrawn
-
1980
- 1980-01-28 GR GR62506A patent/GR69741B/el unknown
- 1980-07-15 ES ES493385A patent/ES8105005A1/es not_active Expired
- 1980-07-17 EP EP80104171A patent/EP0023032A1/de not_active Withdrawn
- 1980-07-17 FI FI802267A patent/FI802267A7/fi not_active Application Discontinuation
- 1980-07-18 NO NO802173A patent/NO802173L/no unknown
- 1980-07-18 DK DK311580A patent/DK311580A/da unknown
- 1980-07-18 AR AR281813A patent/AR227645A1/es active
- 1980-07-21 JP JP9883880A patent/JPS5616486A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES493385A0 (es) | 1981-05-16 |
| ES8105005A1 (es) | 1981-05-16 |
| AR227645A1 (es) | 1982-11-30 |
| JPS5616486A (en) | 1981-02-17 |
| NO802173L (no) | 1981-01-22 |
| EP0023032A1 (de) | 1981-01-28 |
| FI802267A7 (fi) | 1981-01-01 |
| GR69741B (da) | 1982-07-12 |
| DE2929596A1 (de) | 1981-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK29681A (da) | Fremgangsmaade til fremstilling af immunogammaglobulin | |
| DK546080A (da) | Fremgangsmaade til fremstilling af galactosaccharosederivater | |
| DK6180A (da) | Fremgangsmaade til fremstilling af 2-pennemforbindelser | |
| DK365280A (da) | Fremgangsmaade til fremstilling af ftaliminderivater | |
| DK129879A (da) | Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer | |
| DK552180A (da) | Fremgangsmaade til fremstilling af tetrapeptidsemikarbazidderivater | |
| DK274580A (da) | Fremgangsmaade til fremstilling af tripeptidamider | |
| DK149623C (da) | Fremgangsmaade til fremstilling af alfa-hydroxycarboxylsyreamider | |
| DK394080A (da) | Fremgangsmaade til fremstilling af carbostyrilderivater | |
| DK153791C (da) | Fremgangsmaade til fremstilling af 7-hydroxycumaraner | |
| DK481280A (da) | Fremgangsmaade til fremstilling af piperidylbenzimidazolinonderivater | |
| DK262180A (da) | Fremgangsmaade til fremstilling af alkyl-2-chlorpropionater | |
| DK187980A (da) | Fremgangsmaade til fremstilling af benzimidazolderivater | |
| DK274680A (da) | Fremgangsmaade til fremstilling af tripeptidamider | |
| DK222880A (da) | Fremgangsmaade til fremstilling af anthracyclinonderivater | |
| DK304080A (da) | Fremgangsmaade til fremstilling af pyrazoloindazolderivater | |
| DK150471C (da) | Fremgangsmaade til fremstilling af trifluormethylphenoler | |
| DK69680A (da) | Fremgangsmaade til fremstilling af diorganomagnesiumforbindelser | |
| DK145179A (da) | Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol | |
| DK318280A (da) | Fremgangsmaade til fremstilling af naphthyridinderivater | |
| DK546180A (da) | Fremgangsmaade til fremstilling af triazepinderivater | |
| DK199981A (da) | Fremgangsmaade til fremstilling af thiobiscarbamater | |
| DK156427C (da) | Fremgangsmaade til fremstilling af n-alkylarylaminer | |
| DK32580A (da) | Fremgangsmaade til fremstilling af alkylarylethere | |
| DK159155C (da) | Fremgangsmaade til fremstilling af 3-karbamoyloxymetylcephalosporinforbindelser |